These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22901971)

  • 21. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
    O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
    Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.
    Lowenstern AM; Li S; Navar AM; Roger VL; Robinson JG; Goldberg AC; Virani SS; Lee LV; Wilson PWF; Louie MJ; Peterson ED; Wang TY
    J Am Heart Assoc; 2018 Sep; 7(18):e009251. PubMed ID: 30371214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
    Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
    J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.
    Wang KF; Chang CC; Wang KL; Wu CH; Chen LC; Lu TM; Lin SJ; Chiang CE
    J Chin Med Assoc; 2014 Feb; 77(2):61-7. PubMed ID: 24332414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial and ethnic differences in statin prescription and clinical outcomes among hospitalized patients with coronary heart disease.
    Mochari-Greenberger H; Liao M; Mosca L
    Am J Cardiol; 2014 Feb; 113(3):413-7. PubMed ID: 24295550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current cholesterol guidelines and clinical reality: a comparison of two cohorts of coronary artery disease patients.
    Vonbank A; Saely CH; Rein P; Sturn D; Drexel H
    Swiss Med Wkly; 2013; 143():w13828. PubMed ID: 23832393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
    Xian Y; Navar AM; Li S; Li Z; Robinson J; Virani SS; Louie MJ; Koren A; Goldberg A; Roger VL; Wilson PWF; Peterson ED; Wang TY
    J Am Heart Assoc; 2019 Oct; 8(19):e013229. PubMed ID: 31554462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort Study.
    Waldeyer C; Seiffert M; Staebe N; Braetz J; Kohsiack R; Ojeda F; Schofer N; Karakas M; Zeller T; Sinning C; Schrage B; Westermann D; Sydow K; Blankenberg S; Brunner FJ; Schnabel RB
    Clin Ther; 2017 Nov; 39(11):2311-2320.e2. PubMed ID: 29103665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of cholesterol follow-up testing under current statin treatment guidelines.
    Dansinger ML; Williams PT; Superko HR; Schaefer EJ
    Prev Med; 2019 Apr; 121():150-157. PubMed ID: 30742874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treat-to-target lipid control is effective but highlighted poor prognosis without indication of statin following percutaneous coronary intervention.
    Tanaka S; Ikari Y; Ijichi T; Nakazawa G
    Cardiovasc Interv Ther; 2017 Oct; 32(4):358-364. PubMed ID: 27539447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
    Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
    Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: the CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) study.
    Ur E; Langer A; Rabkin SW; Calciu CD; Leiter LA;
    Can J Cardiol; 2010 Feb; 26(2):80-6. PubMed ID: 20151053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.
    Bellamy MF; Pellikka PA; Klarich KW; Tajik AJ; Enriquez-Sarano M
    J Am Coll Cardiol; 2002 Nov; 40(10):1723-30. PubMed ID: 12446053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.